Somatic stem cell marker prominin-1/CD133 is expressed in embryonic stem cell-derived progenitors - PubMed (original) (raw)

Somatic stem cell marker prominin-1/CD133 is expressed in embryonic stem cell-derived progenitors

Gabriela Kania et al. Stem Cells. 2005 Jun-Jul.

Abstract

Prominin-1/CD133 is a plasma membrane marker found in several types of somatic stem cells, including hematopoietic and neural stem cells. To study its role during development and with differentiation, we analyzed its temporal and spatial expression (mRNA and protein) in preimplantation embryos, undifferentiated mouse embryonic stem (ES) cells, and differentiated ES cell progeny. In early embryos, prominin-1 was expressed in trophoblast but not in cells of the inner cell mass; however, prominin-1 transcripts were detected in undifferentiated ES cells. Both ES-derived cells committed to differentiation and early progenitor cells coexpressed prominin-1 with early lineage markers, including the cytoskeletal markers (nestin, cytokeratin 18, desmin), fibulin-1, and valosin-containing protein. After spontaneous differentiation at terminal stages, prominin-1 expression was downregulated and no coexpression with markers characteristic for neuroectodermal, mesodermal, and endodermal cells was found. Upon induction of neuronal differentiation, some prominin-1-positive cells, which coexpressed nestin and showed the typical morphology of neural progenitor cells, persisted until terminal stages of differentiation. However, no coexpression of prominin-1 with markers of differentiated neural cells was detected. In conclusion, we present the somatic stem cell marker prominin-1 as a new parameter to define ES-derived committed and early progenitor cells.

PubMed Disclaimer

Similar articles

• Fetal human hematopoietic stem cells can differentiate sequentially into neural stem cells and then astrocytes in vitro.
  Hao HN, Zhao J, Thomas RL, Parker GC, Lyman WD. Hao HN, et al. J Hematother Stem Cell Res. 2003 Feb;12(1):23-32. doi: 10.1089/152581603321210109. J Hematother Stem Cell Res. 2003. PMID: 12662433
• Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells.
  Blyszczuk P, Czyz J, Kania G, Wagner M, Roll U, St-Onge L, Wobus AM. Blyszczuk P, et al. Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):998-1003. doi: 10.1073/pnas.0237371100. Epub 2003 Jan 13. Proc Natl Acad Sci U S A. 2003. PMID: 12525695 Free PMC article.
• Prominin-1 allows prospective isolation of neural stem cells from the adult murine hippocampus.
  Walker TL, Wierick A, Sykes AM, Waldau B, Corbeil D, Carmeliet P, Kempermann G. Walker TL, et al. J Neurosci. 2013 Feb 13;33(7):3010-24. doi: 10.1523/JNEUROSCI.3363-12.2013. J Neurosci. 2013. PMID: 23407958 Free PMC article.
• Nestin expression--a property of multi-lineage progenitor cells?
  Wiese C, Rolletschek A, Kania G, Blyszczuk P, Tarasov KV, Tarasova Y, Wersto RP, Boheler KR, Wobus AM. Wiese C, et al. Cell Mol Life Sci. 2004 Oct;61(19-20):2510-22. doi: 10.1007/s00018-004-4144-6. Cell Mol Life Sci. 2004. PMID: 15526158 Review.
• AC133/CD133/Prominin-1.
  Shmelkov SV, St Clair R, Lyden D, Rafii S. Shmelkov SV, et al. Int J Biochem Cell Biol. 2005 Apr;37(4):715-9. doi: 10.1016/j.biocel.2004.08.010. Int J Biochem Cell Biol. 2005. PMID: 15694831 Review.

Cited by

• Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers.
  Allegrini G, Di Desidero T, Barletta MT, Fioravanti A, Orlandi P, Canu B, Chericoni S, Loupakis F, Di Paolo A, Masi G, Fontana A, Lucchesi S, Arrighi G, Giusiani M, Ciarlo A, Brandi G, Danesi R, Kerbel RS, Falcone A, Bocci G. Allegrini G, et al. Angiogenesis. 2012 Jun;15(2):275-86. doi: 10.1007/s10456-012-9260-6. Epub 2012 Mar 2. Angiogenesis. 2012. PMID: 22382585 Free PMC article.
• Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern.
  Selman M, Carrillo G, Estrada A, Mejia M, Becerril C, Cisneros J, Gaxiola M, Pérez-Padilla R, Navarro C, Richards T, Dauber J, King TE Jr, Pardo A, Kaminski N. Selman M, et al. PLoS One. 2007 May 30;2(5):e482. doi: 10.1371/journal.pone.0000482. PLoS One. 2007. PMID: 17534432 Free PMC article.
• The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.
  Vander Griend DJ, Karthaus WL, Dalrymple S, Meeker A, DeMarzo AM, Isaacs JT. Vander Griend DJ, et al. Cancer Res. 2008 Dec 1;68(23):9703-11. doi: 10.1158/0008-5472.CAN-08-3084. Cancer Res. 2008. PMID: 19047148 Free PMC article.
• Growth kinetics of CD133-positive prostate cancer cells.
  Reyes EE, Kunovac SK, Duggan R, Kregel S, Vander Griend DJ. Reyes EE, et al. Prostate. 2013 May;73(7):724-33. doi: 10.1002/pros.22616. Epub 2012 Nov 8. Prostate. 2013. PMID: 23138940 Free PMC article.
• CD133 is a marker of bioenergetic stress in human glioma.
  Griguer CE, Oliva CR, Gobin E, Marcorelles P, Benos DJ, Lancaster JR Jr, Gillespie GY. Griguer CE, et al. PLoS One. 2008;3(11):e3655. doi: 10.1371/journal.pone.0003655. Epub 2008 Nov 5. PLoS One. 2008. PMID: 18985161 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • SciCrunch